Welter2008
Welter2008
Welter2008
Background: Tourette syndrome (TS) is thought to Main Outcome Measures: Effects of thalamic, palli-
result from dysfunction of the associative-limbic terri- dal, simultaneous thalamic and pallidal, and sham stimu-
tories of the basal ganglia, and patients with severe lation on neurologic, neuropsychological, and psychiat-
symptoms of TS respond poorly to medication. ric symptoms.
High-frequency stimulation has recently been applied
to patients with TS in open studies using the Results: A dramatic improvement on the Yale Global Tic
centromedian-parafascicular complex (CM-Pf ) of Severity Scale was obtained with bilateral stimulation of
the thalamus, the internal globus pallidus (GPi), or the GPi (reduction in tic severity of 65%, 96%, and 74%
the anterior limb of the internal capsule as the princi- in patients 1, 2, and 3, respectively). Bilateral stimula-
tion of the CM-Pf produced a 64%, 30%, and 40% re-
pal target.
duction in tic severity, respectively. The association of
thalamic and pallidal stimulation showed no further re-
Objective: To report the effect of high-frequency stimu-
duction in tic severity (60%, 43%, and 76%), whereas mo-
lation of the CM-Pf and/or the GPi, 2 associative-limbic tor symptoms recurred during the sham condition. No
relays of the basal ganglia, in patients with TS. neuropsychological, psychiatric, or other long-term ad-
verse effect was observed.
Design: Controlled, double-blind, randomized cross-
over study. Conclusions: High-frequency stimulation of the associa-
tive-limbic relay within the basal ganglia circuitry may be
Setting: Medical research. an effective treatment of patients with TS, thus heighten-
ing the hypothesis of a dysfunction in these structures in
Patients: Three patients with severe and medically re- the pathophysiologic mechanism of the disorder.
fractory TS.
Trial Registration: clinicaltrials.gov Identifier:
Intervention: Bilateral placement of stimulating elec- NCT00139308
trodes in the CM-Pf (associative-limbic part of the thala-
mus) and the GPi (ventromedial part). Arch Neurol. 2008;65(7):952-957
T
OURETTE SYNDROME (TS) IS lation of the centromedian-parafascicular
characterized by motor and complex (CM-Pf) of the thalamus,6 the in-
vocal tics associated with ternal part of the globus pallidus (GPi),7-9
various psychiatric manifes- and the anterior limb of the internal cap-
tations, which can cause sule10 has been tested, with a positive but
major familial and social disability.1 In pa- variable effect on tics. Recently, bilateral
tients with severe and debilitating tics, the stimulation of the CM-Pf and/or the ventro-
best available drug therapy is often inef- oralis nucleus of the thalamus was ap-
fective and has serious potential adverse ef- plied in 18 patients with TS, resulting in a
fects.2,3 Several attempts at neurosurgical 65% improvement in tics.11 However, these
creation of lesions have yielded disappoint- results were obtained at various postop-
Author Affiliations are listed at ing results and severe adverse effects.4,5 In erative delays through an open-label evalu-
the end of this article. sparse case reports, high-frequency stimu- ation. Given the proposed dysfunction of
1, F 2, M 3, F
Age, y
At onset of tics 7 6 13
At time of surgery 36 30 30
Tourette syndrome symptoms
Tics
Motor Eyes, mouth and arms, shoulder shrugs, Eyes, face and arms, head jerks, Eyes, face and arms, head and
touching, copropraxia shoulder shrugs, knee flexion abdominal jerks
Phonic Throat clearing, shouting, coprolalia Throat clearing, shouting, animal Coughing, throat clearing, grunting,
noises animal noises
Self-injurious behaviors Self-inflicted eye lesions, severe lip biting, Jaw biting None
hair tearing, burning
Associated behavioral Borderline personality Arithmomania (mental counting) None
disorders
Treatments
Neuroleptic, mg/d Loxapine succinate, 700; Pimozide, 6; Risperidone, 3;
Pimozide, 18 Tiapride, 300 Loxapine succinate, 25
Others, mg/d Venlafaxine hydrochloride, 300; Fluoxetine hydrochloride, 60; Venlafaxine hydrochloride, 37.5
Clonazepam, 16 Diazepam, 20
Global functioning
Familial Married, living alone, 4-year-old son placed Unmarried, living with mother Divorced, living alone with
with grandparents 3-year-old daughter
Socioprofessional Unemployed for 10 mo (secretary), Unemployed for 19 mo (waiter) Unemployed for 4 mo (checkout
hospitalized in neurologic unit for 10 mo assistant)
METHODS
40
80 16
30
60 12
20
40 8
10
20 4
0
0 0 M–1 M1 M2 M1 M2 M1 M2 M1 M2 M1 M2
M–1 M2 M3 M4 M5 M6 M7 M8 M9 M10 M60 Before After Thalamic Pallidal Thalamic Sham
Surgery Surgery Stimulation Stimulation and Pallidal
Before After Thalamic Pallidal Sham Thalamic Thalamic Stimulation
Surgery Surgery Stimulation Stimulation and Pallidal and Pallidal
Stimulation Stimulation Without Double-blind Period with Stimulation Open
Stimulation Long-term
Follow-up
Patient 2
100 20
20 4
80 16 RESULTS
60 12
EFFECTS OF HIGH-FREQUENCY
40 8 STIMULATION ON TIC SEVERITY
Abbreviations: BAS, Brief Anxiety Scale; BIS, Brief Impulsivity Scale; MADRS, Montgomery and Asberg Depression Scale.
a For episodic memory, working memory, and flexibility scores, high values correspond to better performance; for impulsivity, depression, and anxiety scores,
high values correspond to worse psychiatric status.
b The Trail Making Test A-B produces a reaction time expressed in seconds; the mean normal value is 35 ± 20 seconds.
effects of both thalamic and pallidal stimulation remained reappeared during the sham stimulation condition. De-
stable or increased during the 2-month period in patients pressive mood, emotional hypersensitivity, moderate anxi-
1 and 3. In patient 2, the best result was obtained after 1 ety, and impulsiveness tended to decrease with thalamic
month with stimulation, but the improvement decreased or simultaneous thalamic and pallidal stimulation but not
or disappeared after 2 months. In the sham condition, pa- with pallidal stimulation alone (Table 2). Patient 2 had
tients 1 and 2 experienced a recurrence of motor symp- no psychiatric disorder either before or after surgery
toms, with a severity similar to that observed before sur- (Table 2). Mild anxiety-free mental counting was present
gery. In patient 3, tic severity decreased by 32% in the sham before surgery; it disappeared under both thalamic and/or
condition (Figure 2). pallidal stimulation but reappeared during the sham pro-
cedure. Patient 3 had a moderate generalized anxiety dis-
ADVERSE EFFECTS order, which was controlled at the time of surgery with
venlafaxine hydrochloride therapy (37.5 mg/d). No re-
With therapeutic stimulation settings, transient cheiro-oral surgence of anxiety occurred after surgery despite discon-
or arm paresthesias (lasting a few minutes) or lethargy (3-4 tinuation of venlafaxine therapy (Table 2). None of the 3
days) were induced under thalamic or pallidal stimulation, patients showed obsessive-compulsive symptoms either
respectively. With increasing intensity of pallidal stimula- before or after surgery (not shown).
tion, 2 patients reported sensations of nausea and vertigo Neuropsychological status, which was normal before
and1patientreportedanxiety.Alibidodecreasewasreported surgery, remained stable in all patients (Table 2).
by patient 3 under thalamic stimulation.
LONG-TERM FOLLOW-UP
EFFECTS OF STIMULATION ON PSYCHIATRIC,
NEUROPSYCHOLOGICAL, AND SOCIAL STATUS In patient 1, 60 months after surgery, simultaneous tha-
lamic and pallidal stimulation induced an 82% decrease
Before surgery, patient 1 had a major depressive disorder in tic severity and a dramatic reduction in self-injurious
with severe self-injurious behaviors and impulsiveness, ful- behaviors and impulsiveness (Figure 2). Two years af-
filling the DSM-IV criteria for borderline personality dis- ter surgery, she went back to full-time work and began
order.16 Self-injurious behaviors were dramatically re- interpersonal psychotherapy, which enabled an improve-
duced by pallidal and/or thalamic stimulation, but they ment in interpersonal relationships. Four years after sur-
Announcement